Release form:
1.5 ml syringe
HA concentration:
1.4% (14 mg/ml)
Molecular weight:
3 million Da (3000 kDa)
Composition:
Hyaluronic acid modified with vitamin C, L-carnitine.
Application:
- Pronounced age-related changes in the skin of the face and body.
- Dry, dehydrated skin.
- Age-related decrease in skin elasticity and firmness with a tendency to swelling and pastosity.
- Gravitational ptosis.
- Small local fat deposits in the face and body.
- Prevention of age-associated changes in the shape of the face due to the heaviness of the lower part (hypertrophy).
- Sagging and "excess" skin after local lipolytic therapy.
Clinical effects:
- Improving skin quality, anti-age.
- Skin moisturizing.
- Correction of sagging skin. Increasing skin elasticity.
- Reduction of local fat deposits. Indirect lipolytic and drainage effect (reduction of the "double chin", "jowls", etc.).
- Prevention of tissue ptosis during weight loss.
- Reduction of swelling.
- Improvement of complexion.
- «Accumulative» effect.
Recommended course:
3-5 procedures once every 2 weeks
Registration certificate:
RU FSR 2010/06572
Manufacturer:
Laboratory THOSCANE